Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults
Sixty-six individuals (median age 54; range 22–95) with no history of SARS-CoV-2 infection or related symptoms (hereafter ‘unexposed’) were recruited...